Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;15(1):e2023045.
doi: 10.4084/MJHID.2023.045. eCollection 2023.

Hemoglobin H Disease and Growth: A Comparative Study of DHbH and NDHbH Patients

Issanun Hunnuan  1 , Kleebsabai Sanpkit  1 , Ornsuda Lertbannaphong  2 , Jassada Buaboonnam  1
Affiliations

Hemoglobin H Disease and Growth: A Comparative Study of DHbH and NDHbH Patients

Issanun Hunnuan et al. Mediterr J Hematol Infect Dis. .

Abstract

Background: Hemoglobin H disease (HbH), a hemoglobinopathy resulting from abnormal alpha globin genes, is classified into two categories: deletional HbH (DHbH) and non-deletional HbH (NDHbH). The alpha-mutation genotypes exhibit a range of clinical anemias, which differentially impact patient growth.

Objectives: This retrospective study assessed the growth of HbH patients at Siriraj Hospital, Mahidol University.

Methods: Patients diagnosed with HbH between January 2005 and April 2021 were analyzed using growth standard scores of the Thai Society for Pediatric Endocrinology (2022 version) and BMI-for-age Z scores of the World Health Organization. Growth failure was defined as a patient's height for age exceeding two standard deviations below the mean.

Results: Of the 145 HbH patients, 75 (51.7%) had NDHbH, with --SEA/αCSα being the most common genotype (70 patients; 93.3%). The mean baseline hemoglobin level was significantly lower in NDHbH patients than in DHbH patients (8.16 ± 0.93 g/dL vs. 9.51 ± 0.68 g/dL; P < 0.001). Splenomegaly and growth failure prevalences were higher in NDHbH patients (37.3% vs. 0%, with P < 0.001, and 22.7% vs. 8.6%, with P = 0.020, respectively). Multivariable analysis revealed splenomegaly > 3 cm was associated with growth failure (OR = 4.28; 95% CI, 1.19-15.39; P = 0.026).

Conclusions: NDHbH patients exhibited lower hemoglobin levels and more pronounced splenomegaly than DHbH patients. Growth failure can occur in both HbH types but appears more prevalent in NDHbH. Close monitoring of growth velocity is essential, and early treatment interventions may be required to prevent growth failure.

Keywords: Alpha-thalassemia; Genotypes; Growth failure; Hemoglobin H disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

References

    1. Muncie HL, Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339–44. - PubMed
    1. Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167. doi: 10.1016/S0140-6736(17)31822-6. - DOI - PubMed
    1. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011;364(8):710–8. doi: 10.1056/NEJMoa1010174. - DOI - PubMed
    1. Bhat VS, Dewan KK, Krishnaswamy PR. The diagnosis of α-Thalassaemia: A Case of Hemoglobin H -α Deletion. Indian J Clin Biochem. 2010;25:435–40. doi: 10.1007/s12291-010-0053-7. - DOI - PMC - PubMed
    1. Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program. 2009:26–34. doi: 10.1182/asheducation-2009.1.26. - DOI - PubMed